Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions

Susana Almeida, Augusto Filipe, Rita Neves, Fethi Trabelsi

Clinical Therapeutics · 2009 · 16 citations · 2 references

Concepts

References

2